George Clark - Nov 23, 2021 Form 4 Insider Report for Biohaven Pharmaceutical Holding Co Ltd. (BHVN)

Role
VP, Chief Accounting Officer
Signature
/s/ George C. Clark
Stock symbol
BHVN
Transactions as of
Nov 23, 2021
Transactions value $
-$205,761
Form type
4
Date filed
11/26/2021, 03:26 PM
Previous filing
Aug 13, 2021
Next filing
Dec 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHVN Common Shares Options Exercise $62.1K +1.92K +34.45% $32.42* 7.47K Nov 23, 2021 Direct
transaction BHVN Common Shares Options Exercise $0 +5K +66.91% $0.00 12.5K Nov 26, 2021 Direct
transaction BHVN Common Shares Tax liability -$268K -2.32K -18.58% $115.55* 10.2K Nov 26, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Employee Stock Option (right to buy) Options Exercise $0 -1.92K -28.54% $0.00 4.8K Nov 23, 2021 Common Shares 1.92K $32.42 Direct F2
transaction BHVN Restricted Share Unit Award Options Exercise $0 -5K -25% $0.00 15K Nov 26, 2021 Common Shares 5K Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
F2 The shares underlying this option vest in four equal installments on November 20, 2019, 2020, 2021 and 2022, subject to the reporting person's continued service with the issuer at each vesting date.
F3 Each restricted share unit represents the contingent right to receive one common share of the issuer.
F4 The reporting person was granted 20,000 restricted share units on May 7, 2021, vesting in four equal installments on May 7, 2021, 2022, 2023 and 2024 subject to the reporting person's continued service with the issuer at each vesting date.
F5 Not applicable.